Hybrid Conferencee

International Conference on Neurology and Neuro-oncology (ICNNO - 27)

23rd - 24th June 2027 | Shiraz, Iran
Sample Abstract
Download
Conference Brochure
Sample Full Paper
Download
Expand the Academic Reach of Your Research - a Q1-ranked and Scopus-indexed journal publication opportunity

Journal consideration and publication are subject to editorial review, peer review and applicable journal policies.

Conference Notifications:

"Be sure to check this section regularly for all Research Plus International Conference updates. We’ll keep you informed about deadlines, event details, and more important notifications."

Call for Papers Extended:
"The deadline for full paper submissions has been extended for the Research Plus International Conference in Shiraz. Submit your research by today to participate in one of the top conferences."
Certificate of Presentation:
"Present your research and receive a Certificate of Presentation to recognise your valuable contribution to the conference."
Abstract Submissions Open:
"Abstract submissions for the Shiraz event are now open! Don’t miss the chance to present your research. Submit now."
Networking with Global Experts:
"Engage with researchers and professionals from around the world at the Shiraz conference. Build collaborations and gain insights from leading experts."
Keynote Speaker Sessions:
"Don’t miss our Keynote Sessions in Shiraz, featuring global leaders and innovators sharing their knowledge."
Best Paper & Best Paper Presentation Award:
"Submit your paper and stand a chance to win the Best Paper Presentation Award. The winner will be recognized at the conference in Shiraz."
SDG-Inspired Conference Focus:
"Our conference will highlight research that addresses global sustainability, inclusive education, and solutions for environmental challenges."

Conference Session Tracks

SDG Wheel

Aligned with

UN Sustainable Development Goals

This conference contributes to global sustainability by aligning its research discussions and academic sessions with key United Nations Sustainable Development Goals. It fosters knowledge exchange, innovation, and collaborative engagement.

SDG 3
SDG 3 Good Health and Well-being
SDG 4
SDG 4 Quality Education
SDG 9
SDG 9 Industry, Innovation and Infrastructure
Track 01

Advancements in Neuro-oncology: Current Trends and Future Directions

This session will explore the latest advancements in neuro-oncology, focusing on innovative therapies and treatment modalities for brain tumors. Participants will discuss the implications of these developments for clinical practice and patient outcomes.

Track 02

Neuroimaging Techniques in Brain Tumor Diagnosis

This track will delve into the role of advanced neuroimaging techniques in the diagnosis and monitoring of brain tumors. Emphasis will be placed on the integration of imaging modalities to enhance diagnostic accuracy and treatment planning.

Track 03

Biomarkers in Neuro-oncology: Clinical Applications and Research

This session will focus on the identification and validation of tumor biomarkers in neuro-oncology. Discussions will center on their potential to guide therapeutic decisions and improve patient stratification.

Track 04

Innovations in Neurosurgery for Brain Tumor Management

This track will highlight cutting-edge surgical techniques and technologies in the management of brain tumors. Experts will share insights on minimally invasive approaches and their impact on patient recovery and outcomes.

Track 05

Metastatic Brain Tumors: Challenges and Strategies

This session will address the complexities associated with metastatic brain tumors, including diagnosis, treatment challenges, and patient management strategies. Participants will explore multidisciplinary approaches to improve care for affected patients.

Track 06

Clinical Trials in Neuro-oncology: Design and Implementation

This track will examine the design and implementation of clinical trials in neuro-oncology, focusing on innovative trial methodologies and patient recruitment strategies. Discussions will also cover regulatory considerations and ethical implications.

Track 07

Neuro-oncologic Therapy: Emerging Agents and Combinations

This session will review emerging therapeutic agents and combination therapies in the treatment of brain tumors. Participants will discuss the mechanisms of action and clinical efficacy of these novel approaches.

Track 08

Neuroscience Research: Bridging Basic Science and Clinical Applications

This track will explore the intersection of neuroscience research and clinical neuro-oncology, highlighting how basic science discoveries can inform clinical practice. Emphasis will be placed on translational research and its impact on patient care.

Track 09

Quality of Life and Supportive Care in Neuro-oncology

This session will focus on the importance of quality of life and supportive care for patients with brain tumors. Discussions will include psychosocial support, palliative care, and strategies to enhance patient well-being.

Track 10

Ethical Considerations in Neuro-oncology Research and Practice

This track will address the ethical challenges faced in neuro-oncology research and clinical practice. Participants will engage in discussions on informed consent, patient autonomy, and the implications of emerging therapies.

Track 11

Future Directions in Neuro-oncology: A Global Perspective

This session will provide a global perspective on the future directions of neuro-oncology, including international collaborations and research initiatives. Participants will discuss the challenges and opportunities in advancing neuro-oncologic care worldwide.